Transpire Bio’s ANDA for Generic High-Strength Trelegy® Ellipta® Accepted for Filing by the U.S. FDA
SUNRISE, Fla., May 11, 2026 /PRNewswire/ — Transpire Bio Inc., an integrated clinical-stage biopharmaceutical company developing inhaled therapeutics…